BioNTech SE (BNTX)
NASDAQ·Healthcare·Biotechnology
$93.05
+3.97%
Mkt Cap $24.56B
Analyst Ratings
No recent rating data.
Price Target (44 analysts)
$137.38
Range $113.00 – $155.00
Implied Upside
+47.6%
Consensus $137.38 vs current $93.05
NASDAQ·Healthcare·Biotechnology
$93.05
+3.97%
Mkt Cap $24.56B
No recent rating data.
Price Target (44 analysts)
$137.38
Range $113.00 – $155.00
+47.6%
Consensus $137.38 vs current $93.05